The new drug is meant to treat specific types of advanced breast cancer which are resistant to hormone therapy.

Goshen Township, Ohio - An Ohio mom battling cancer was left "very surprised" after local police officers shaved their heads ...

The Staten Island Board of Realtors (SIBOR), in conjunction with the American-Italian Cancer Foundation, will host free ...

Breast cancer screening rates shifted after the 2009 US Preventive Services Task Force (USPSTF) guidelines, with disparities ...

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

A Michigan mother is suing her former workplace, claiming they unlawfully fired her for taking medical leave to care for her ...

The NAACP is urging cancer be declared as a public health crisis in the Black community in response to troubling CDC research.

Stage actress Kara Lindsay is "celebrating closing [a] massive chapter" after revealing her breast cancer diagnosis. The ...

The Crimora Players will present "The Dearly Undeparted" by Michael Soetaert the weekend after Valentine's Day.

The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.